...- On April 30, 2024, 3M Co. announced its first indications of a lower dividend, following the spinoff of its health care business, Solventum, earlier in the month. - As a result, we estimate 3M should have sufficient cash flow in 2024 and 2025 to reduce its S&P Global Ratings-adjusted debt leverage to below 3x from 3.3x as of Dec. 31, 2023. - We affirmed our '###+' issuer credit rating on 3M and removed it from CreditWatch with negative implications, where we placed it on July 26, 2022. - The outlook is negative, reflecting the risk that any combination of share repurchases, weaker earnings, or more debt-like obligations could keep debt leverage above 3x for another year or two. 3M's debt leverage has little cushion early in 2024, but robust cash flow should enable the company to lower leverage to around 2.5x in 2025....